191 related articles for article (PubMed ID: 29067881)
41. Melanoma: is immunotherapy of benefit?
Faries MB; Morton DL
Adv Surg; 2003; 37():139-69. PubMed ID: 12953631
[No Abstract] [Full Text] [Related]
42. Autologous cytokine-induced killer (CIK) immunotherapy in a case of disseminated tuberculosis.
Ping X; Junchi X; Xinnian C; Zhijian Y; Meiying W
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):83-6. PubMed ID: 26237360
[TBL] [Abstract][Full Text] [Related]
43. Cancer Immunotherapy with Cytokine-Induced Killer Cells.
Mata-Molanes JJ; Sureda González M; Valenzuela Jiménez B; Martínez Navarro EM; Brugarolas Masllorens A
Target Oncol; 2017 Jun; 12(3):289-299. PubMed ID: 28474278
[TBL] [Abstract][Full Text] [Related]
44. TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis.
He G; Zheng C; Huo H; Zhang H; Zhu Z; Li J; Zhang H
Int Immunopharmacol; 2016 Nov; 40():436-442. PubMed ID: 27716591
[TBL] [Abstract][Full Text] [Related]
45. Killing effects of Huaier Granule combined with DC-CIK on nude mice transplanted with colon carcinoma cell line.
Sun WW; Dou JX; Zhang L; Qiao LK; Shen N; Zhao Q; Gao WY
Oncotarget; 2017 Jul; 8(28):46081-46089. PubMed ID: 28537906
[TBL] [Abstract][Full Text] [Related]
46. Combination of PD-1 blockade and RetroNectin
Zhao L; Han L; Zhang Y; Li T; Yang Y; Li W; Shang Y; Lin H; Gao Q
Immunotherapy; 2018 Nov; 10(15):1315-1323. PubMed ID: 30350739
[TBL] [Abstract][Full Text] [Related]
47. Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up.
Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
Cancer Immunol Immunother; 2019 Jan; 68(1):23-32. PubMed ID: 30232520
[TBL] [Abstract][Full Text] [Related]
48. Immunotherapy of melanoma.
Parmiani G; Castelli C; Rivoltini L; Casati C; Tully GA; Novellino L; Patuzzo A; Tosi D; Anichini A; Santinami M
Semin Cancer Biol; 2003 Dec; 13(6):391-400. PubMed ID: 15001157
[TBL] [Abstract][Full Text] [Related]
49. Combined Treatment with Autologous CIK Cells, Radiotherapy and Chemotherapy in Advanced Cervical Cancer.
Li N; Tian YW; Xu Y; Meng DD; Gao L; Shen WJ; Liu ZL; Xu ZQ
Pathol Oncol Res; 2019 Apr; 25(2):691-696. PubMed ID: 30511107
[TBL] [Abstract][Full Text] [Related]
50. Immunotherapy with cytokine-induced killer cells as an adjuvant treatment for advanced gastric carcinoma: a retrospective study of 165 patients.
Zhao H; Fan Y; Li H; Yu J; Liu L; Cao S; Ren B; Yan F; Ren X
Cancer Biother Radiopharm; 2013 May; 28(4):303-9. PubMed ID: 23506427
[TBL] [Abstract][Full Text] [Related]
51. Clinical effects of immunotherapy of DC-CIK combined with chemotherapy in treating patients with metastatic breast cancer.
Mao Q; Li L; Zhang C; Sun Y; Liu S; Cui S
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1055-8. PubMed ID: 26051718
[TBL] [Abstract][Full Text] [Related]
52. Combination of chemotherapy and immunotherapy for colon cancer in China: a meta-analysis.
Wang ZX; Cao JX; Liu ZP; Cui YX; Li CY; Li D; Zhang XY; Liu JL; Li JL
World J Gastroenterol; 2014 Jan; 20(4):1095-106. PubMed ID: 24574784
[TBL] [Abstract][Full Text] [Related]
53. Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.
Oelsner S; Wagner J; Friede ME; Pfirrmann V; Genßler S; Rettinger E; Buchholz CJ; Pfeifer H; Schubert R; Ottmann OG; Ullrich E; Bader P; Wels WS
Int J Cancer; 2016 Oct; 139(8):1799-809. PubMed ID: 27253354
[TBL] [Abstract][Full Text] [Related]
54. Proteomic Identification of Heat Shock-Induced Danger Signals in a Melanoma Cell Lysate Used in Dendritic Cell-Based Cancer Immunotherapy.
González FE; Chernobrovkin A; Pereda C; García-Salum T; Tittarelli A; López MN; Salazar-Onfray F; Zubarev RA
J Immunol Res; 2018; 2018():3982942. PubMed ID: 29744371
[TBL] [Abstract][Full Text] [Related]
55. Cytokine-induced Killer T Cells Enhance the Cytotoxicity Against Carboplatin-resistant Ovarian Cancer Cells.
Pan Y; Chiu YH; Chiu SC; Cho DY; Lee LM; Wen YC; Whang-Peng J; Hsiao CH; Shih PH
Anticancer Res; 2020 Jul; 40(7):3865-3872. PubMed ID: 32620626
[TBL] [Abstract][Full Text] [Related]
56. Profiling the dynamic expression of checkpoint molecules on cytokine-induced killer cells from non-small-cell lung cancer patients.
Zhang L; Wang J; Wei F; Wang K; Sun Q; Yang F; Jin H; Zheng Y; Zhao H; Wang L; Yu W; Zhang X; An Y; Yang L; Zhang X; Ren X
Oncotarget; 2016 Jul; 7(28):43604-43615. PubMed ID: 27283895
[TBL] [Abstract][Full Text] [Related]
57. Tumor MICA status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer.
Chen Y; Lin WS; Zhu WF; Lin J; Zhou ZF; Huang CZ; Chen G; Shi Y; Guo ZQ; Ye YB
Immunol Res; 2016 Feb; 64(1):251-9. PubMed ID: 26607264
[TBL] [Abstract][Full Text] [Related]
58. Autologous dendritic cells combined with cytokine-induced killer cells synergize low-dose chemotherapy in elderly patients with acute myeloid leukaemia.
Dong M; Liang D; Li Y; Kong D; Kang P; Li K; Ping C; Zhang Y; Zhou X; Zhang Y; Hong L
J Int Med Res; 2012; 40(4):1265-74. PubMed ID: 22971478
[TBL] [Abstract][Full Text] [Related]
59. Randomized study of autologous cytokine-induced killer cell immunotherapy in metastatic renal carcinoma.
Liu L; Zhang W; Qi X; Li H; Yu J; Wei S; Hao X; Ren X
Clin Cancer Res; 2012 Mar; 18(6):1751-9. PubMed ID: 22275504
[TBL] [Abstract][Full Text] [Related]
60. The Efficacy of CIK-Based Immunotherapies for Advanced Solid Tumors.
Chu H; Du F; Jiang L; Wang Z; Gong Z; Lian P; Li P; Chen J
Technol Cancer Res Treat; 2017 Oct; 16(5):577-585. PubMed ID: 27436839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]